Body Mass Index impacts the choice of lipid lowering treatment with no correlation to blood cholesterol – findings from 52,916 patients in the Dyslipidemia International Study (DYSIS)

Diabetes, Obesity and Metabolism,Volume 0, Issue ja, -Not available-.

Source: Diabetes, Obesity and Metabolism - June 11, 2018 Category: Endocrinology Authors: Jean Ferri ères , Dominik Lautsch , Anselm K. Gitt , Gaetano De Ferrari , Hermann Toplak , Moses Elisaf , Heinz Drexel , Martin Horack , Carl Baxter , Baishali Ambegaonkar , Philippe Brudi , Peter P. Toth Source Type: research